Truist Financial Corp Charles River Laboratories International, Inc. Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 34,192 shares of CRL stock, worth $6.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

34,192

Previous 37,224 8.15%

Holding current value

$6.81 Million

Previous $7.69 Million 12.41%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$187.96 - $245.29 $569,894 - $743,719	-3,032 Reduced 8.15%	34,192 $6.74 Million
Q2 2024 Aug 20, 2024	SELL	$206.39 - $268.73 $569,842 - $741,963	-2,761 Reduced 6.91%	37,224 $7.69 Million
Q1 2024 May 10, 2024	SELL	$203.52 - $273.43 $197,414 - $265,227	-970 Reduced 2.37%	39,985 $10.8 Million
Q4 2023 Feb 02, 2024	SELL	$164.52 - $238.84 $181,959 - $264,157	-1,106 Reduced 2.63%	40,955 $9.68 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $244,022 - $273,100	1,255 Added 3.08%	42,061 $8.24 Million
Q2 2023 Aug 01, 2023	SELL	$183.71 - $210.25 $96,815 - $110,801	-527 Reduced 1.28%	40,806 $8.58 Million
Q1 2023 May 05, 2023	BUY	$191.89 - $259.92 $199,181 - $269,796	1,038 Added 2.58%	41,333 $8.34 Million
Q4 2022 Feb 17, 2023	BUY	$197.11 - $250.07 $112,352 - $142,539	570 Added 1.43%	40,295 $8.78 Million
Q3 2022 Oct 26, 2022	BUY	$182.44 - $250.54 $416,145 - $571,481	2,281 Added 6.09%	39,725 $7.82 Million
Q2 2022 Jul 22, 2022	SELL	$204.13 - $302.4 $427,856 - $633,830	-2,096 Reduced 5.3%	37,444 $8.01 Million
Q1 2022 Apr 22, 2022	BUY	$255.51 - $362.11 $1.3 Million - $1.84 Million	5,085 Added 14.76%	39,540 $11.2 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $401,978 - $513,289	1,144 Added 3.43%	34,455 $13 Million
Q3 2021 Nov 05, 2021	BUY	$372.64 - $458.3 $515,733 - $634,287	1,384 Added 4.33%	33,311 $13.7 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $622,757 - $786,783	2,117 Added 7.1%	31,927 $11.8 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $388,236 - $465,691	1,555 Added 5.5%	29,810 $8.64 Million
Q4 2020 Nov 19, 2021	SELL	$222.0 - $252.62 $484,626 - $551,469	-2,183 Reduced 7.17%	28,255 $7.06 Million
Q4 2020 Feb 18, 2021	BUY	$222.0 - $252.62 $448,884 - $510,797	2,022 Added 7.12%	30,438 $7.61 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $725,413 - $935,691	-4,132 Reduced 12.7%	28,416 $6.44 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $619,869 - $989,579	-5,216 Reduced 13.81%	32,548 $5.68 Million
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $38,274 - $69,017	-387 Reduced 1.01%	37,764 $4.77 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $1.7 Million - $2.05 Million	13,448 Added 54.44%	38,151 $5.83 Million
Q3 2019 Oct 31, 2019	SELL	$125.07 - $143.67 $71,790 - $82,466	-574 Reduced 2.27%	24,703 $3.27 Million
Q2 2019 Jul 24, 2019	SELL	$123.4 - $148.55 $147,216 - $177,220	-1,193 Reduced 4.51%	25,277 $3.59 Million
Q1 2019 Apr 23, 2019	SELL	$104.82 - $146.73 $15,198 - $21,275	-145 Reduced 0.54%	26,470 $3.85 Million
Q4 2018 Jan 22, 2019	BUY	$105.09 - $137.23 $46,659 - $60,930	444 Added 1.7%	26,615 $3.01 Million
Q3 2018 Oct 17, 2018	SELL	$112.11 - $134.54 $107,177 - $128,620	-956 Reduced 3.52%	26,171 $3.52 Million
Q2 2018 Jul 26, 2018	SELL	$102.37 - $117.25 $205,149 - $234,969	-2,004 Reduced 6.88%	27,127 $3.05 Million
Q1 2018 Apr 20, 2018	SELL	$98.19 - $115.2 $192,943 - $226,368	-1,965 Reduced 6.32%	29,131 $3.11 Million
Q4 2017 Jan 29, 2018	SELL	$100.43 - $118.09 $64,476 - $75,813	-642 Reduced 2.02%	31,096 $3.4 Million
Q3 2017 Oct 23, 2017	BUY	$96.72 - $109.26 $3.07 Million - $3.47 Million	31,738	31,738 $3.43 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Charles River Laboratories International, Inc. Transaction History